Would you continue SAPT beyond 12 months after left main stenting in an elderly patient on DOAC for paroxysmal atrial fibrillation?
Answer from: at Academic Institution
From the results of the AFIRE trial, the ACC Expert Consensus recommends discontinuing all antiplatelet agents in patients with atrial fibrillation and stable ischemic heart disease who are on a DOAC and are >1 year post-PCI or CABG.LM PCI gives one a smallmargin for error and maintaining Clopido...